Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.50 -1.28% 116.00 115.00 117.00 117.50 116.00 117.50 18,390 11:27:53
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 6.1 -13.9 -35.9 - 66

Reneuron Share Discussion Threads

Showing 7726 to 7749 of 8350 messages
Chat Pages: Latest  310  309  308  307  306  305  304  303  302  301  300  299  Older
DateSubjectAuthorDiscuss
06/12/2019
11:27
I'm no chartist but after going sideways to slightly up since October, the price has now moved above the 50 day weighted moving average. The unweighted 50 day moving average is circa 144p. With no news coming that is likely to be bad, and a couple of significant positives (a deal, Woodford's holding) in the offing, I've added this morning.
dickbush
06/12/2019
10:59
Looks like a triple bottom chartwise
volsung
06/12/2019
10:42
From the webcast: Following a protocol amendment next year a further 6 to 12 patients will be added to the RPC trial. Hoping to move straight to a phase 3 trial after results of the 2a trial. Patients would have both eyes treated and the control group would have no treatment. To avoid surgical related incidents, patients with very poor retinas unlikely to be treated. Moving to 2/3rds of patients being treated in the stroke trials. They were losing patients from the trial because the 50:50 odds were deemed too low.
dickbush
06/12/2019
09:09
Napoleon 14th. The cash burn of £5.15 mil was for one half, a period when they received a net £5.4 mil from Fosun. Without another Fosun payment they would have zero cash by September 30th 2020 and that's not even taking into account the major increase in spending required for a much greater number of patients in the CTX trial. The company needs money, probably a lot of it. The guy who was hired some six months ago to do Fosun-like deals needs to start earning his salary. With a deal or deals the share price should appreciate mightily, particularly once Woodford's shares are distributed. But the higher they go, the more certain is a placing or rights issue IMO.
dickbush
06/12/2019
08:37
"In the months ahead" is rather open-ended though. Anyone could interpret that to mean years ahead as months lead to years. Will hold and possibly top-up on any major weakness, but in hindsight should have sold in the 300p area and bought back. If only I was a trader!
lauders
06/12/2019
08:26
The best part for me was "We hope to be able to announce further deals with commercial third parties across our various programmes in the months ahead." They must be reasonably confident in this to state a time frame. Any further deals will provide a real confidence boost in the products and the progress they are making.
stevedd
06/12/2019
08:24
Looks OK. Cash = £21.3M, 2019 cashburn = £5.15M, so basically we have 4 years before needing funds, in the absence of any further progress in financial performance. Progress depends on scientific performance and saleability, about which I can only take the experts' words as I know nothing, like Manuel... Needs to get the Woodford factor done and dusted. I'll keep what shares I have here, reduced to a free carry. Might even add some if the chart looks positive.
napoleon 14th
06/12/2019
08:23
Perhaps we will now see the share price move back to more sensible levels.
bonzo
06/12/2019
08:15
Bought back in at 137p
volsung
06/12/2019
07:40
Rns reads well, all going well it seems
ayl30
29/11/2019
11:00
I'm no chartist but this has rallied up to its 50 day weighted moving average. Some speculation re the statement in a week's time or the reducing time to the resolution of the share overhang? Or just a nod to what has happened to IMM.
dickbush
28/11/2019
16:23
I see that Immupharma is up 325% on a US deal. The product has already done a Phase III trial with results a long way short of perfect. Now moving to a Phase III trial using patients who are much more likely to benefit. Sounds familiar.
dickbush
28/11/2019
10:03
Yes, this time next year Rodney.
small crow
28/11/2019
00:04
Stay positive - Those who know the technology are ...There's much more to come.
alimo
26/11/2019
10:35
Re Woodford Equity Income Fund. "BlackRock has been tasked with selling down the bulk of the fund's quoted stocks while PJT Park Hill will offload unquoted companies and selected listed but hard-to-trade small companies, ahead of a first distribution to investors expected in January." Rene was over £3 when Woodford's problems became public. Even taking into account the poorer than expected results from the RP update, we should see a much higher price once Woodford's Funds' holding is sold. The problem for the share price is getting from here to there. I hope to see a resolution by end-January 2020. I don't expect the results in ten days time to make much difference unless they have news on a Fosun-like deal. It's about time the guy who was hired to make such deals started to earn his salary.
dickbush
25/11/2019
21:50
Thank u for your fed back
hadley 1
25/11/2019
14:24
Someone seems to be offloading today even though the share price is so low. They must need the money. Woodford perhaps?
investordave
23/11/2019
05:39
Also a new presentation I believe: Http://www.reneuron.com/wp-content/uploads/ReNeuron-corporate-presentation-Nov-2019.pdf Results on 6th December. Perhaps we will have to wait until 2020 for the next major news though.
lauders
19/11/2019
16:19
Update research note on data presented by RENE out from Equity Development, freely accessible here : https://www.equitydevelopment.co.uk/edreader/?ltkn=[ID]&d=%3D%3DQO1YjM
edmonda
18/11/2019
10:47
Half year results coming out on December 6th. Amount of cash they had left will be interesting.
dickbush
13/11/2019
19:24
Stupid boy.
investordave
13/11/2019
13:54
Normal service to be resumed here soon, sub 50 on its way!.. en-route to a delist and asset transfer into private hands!.. with a zero return to the beloved long term, including latest cohort of mug punter holders. Hope this helps
rocket fuel
11/11/2019
22:11
Hi Hadley, Yes 100/1, so that would have been £1.70.
philh75
11/11/2019
21:33
Just wanted to get some information about RENEURON as me and a mate brought shares a in 2016 at 1.7p there now at 125p today.. my friend is now saying there as been a reverse stock split and we are still at where we started with them.. does anyone have any information about this or is this false?
hadley 1
Chat Pages: Latest  310  309  308  307  306  305  304  303  302  301  300  299  Older
ADVFN Advertorial
Your Recent History
LSE
RENE
Reneuron
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210623 11:08:34